Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial
| Image |  |
|---|---|
| Description | scientific article published on 9 April 2013 |
| Author/s |
author: Philip W. Kantoff |
| Publication date | April 9, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |